Elderly people who live in the Tang Qiao Community of the Pudong new district of Shanghai receive home-based health care thanks to Project Hope, a recipient of a grant from The Baxter International Foundation.
Improving access to healthcare is a global challenge. This issue is especially pressing in developing countries, where poor infrastructure, political instability, poverty, lack of education, restrictive regulatory environments, and inadequate availability and affordability of medical products can all limit access. Developing solutions requires cooperation among governments, non-governmental organizations, corporations, medical professionals and others.
Baxter produces life-saving and life-sustaining products and therapies in the form of biologics, devices and specialized pharmaceuticals (such as intravenous solutions and anesthetic agents) that are typically administered in a hospital or clinical setting. The company collaborates with government partners to expand access to quality care, while improving health outcomes and controlling costs. For example, Baxter partners with Hemobrás (Empresa Brasileira de Hemoderivados e Biotechnologia) in Brazil to provide people with hemophilia greater access to recombinant FVIII treatment. Learn more in the Advancing Public Health section.
In every aspect of its business, Baxter respects and is committed to fostering human rights, dignity and the diverse contributions of all. Baxter’s Global Human Rights Policy, which follows the Universal Declaration of Human Rights, details the company’s commitment in this area.
Baxter works to expand access to its products and technologies while also protecting its intellectual property to support its ongoing commercial success. Please see Baxter’s Annual Report Form 10-K for more information.